LIMERICK, Pa., Jun 01, 2011 (BUSINESS WIRE) --
Teleflex Incorporated (NYSE: TFX) ("Teleflex") today announced the
registered public offering, subject to market and other conditions, of
$250 million of senior subordinated unsecured notes due 2021 (the
"notes"). The notes will be guaranteed by certain of Teleflex's
subsidiaries on a senior subordinated unsecured basis. The interest rate
and other terms of the notes will be determined at pricing.
Teleflex intends to use the net proceeds of the offering to prepay $125
million of borrowings under its credit facilities, and the remainder for
general corporate purposes, which may include, among other things,
capital expenditures, acquisitions and additional repayment of debt.
BofA Merrill Lynch, Goldman, Sachs & Co. and J.P. Morgan will act as
joint book-running managers for the offering.
You may obtain a copy of the preliminary prospectus supplement, the
accompanying prospectus and the final prospectus supplement for the
offering, when available, from the SEC website at www.sec.gov.
Alternatively, the underwriters will arrange to send you these documents
if you request them by contacting BofA Merrill Lynch at 4 World
Financial Center, New York, NY 10080, Attention: Prospectus Department
or emailing dg.prospectus_requests@baml.com,
Goldman, Sachs & Co. at 200 West Street, New York, NY 10282, (866)
471-2526 or emailing prospectus-ny@ny.email.gs.com
or J.P. Morgan at 383 Madison Avenue, 3rd Floor New York, NY 10179,
(800) 245-8812.
The offering will be made pursuant to an effective shelf registration
statement filed with the Securities and Exchange Commission ("SEC").
This press release shall not constitute an offer to buy or sell or the
solicitation of an offer to buy or sell any securities. The offering is
not being made in any jurisdiction in which the making or acceptance
thereof would not be in compliance with the securities laws, blue sky
laws or other laws of such jurisdiction or is otherwise prohibited.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Its mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Limerick, PA,
Teleflex employs approximately 12,000 people worldwide and serves
healthcare providers in more than 130 countries. The company also has
niche businesses which produce specialty engineered products for the
aerospace market.
Caution Concerning Forward-Looking Information
This press release contains forward-looking statements. Actual results
could differ materially from those in the forward-looking statements due
to, among other things, Teleflex's ability to comply with government
regulation to which it is subject; changes in business relationships
with and purchases by or from major customers or suppliers, including
delays or cancellations in shipments; demand for and market acceptance
of new and existing products; Teleflex's ability to resolve, to the
satisfaction of the U.S. Food and Drug Administration, the issues
identified in the corporate warning letter issued to its subsidiary
Arrow International, Inc.; Teleflex's ability to integrate acquired
businesses into its operations, realize planned synergies and operate
such businesses profitably in accordance with expectations; Teleflex's
ability to effectively execute its restructuring programs; the impact of
recently passed healthcare reform legislation and changes in Medicare,
Medicaid and third-party coverage and reimbursements; competitive market
conditions and resulting effects on revenues and pricing; increases in
raw material costs that cannot be recovered in product pricing; global
economic factors, including currency exchange rates and interest rates;
difficulties entering new markets; and general economic conditions; and
other factors described in Teleflex's filings with the SEC, including
its Annual Report on Form 10-K and the preliminary prospectus supplement
relating to the offering of the securities.
SOURCE: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Vice President Investor Relations
610-948-2836